New filler faces off against juvederm in Mid-Face volume trial
NCT ID NCT07265778
First seen Dec 18, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study compares a new injectable filler, JTM102, to an existing one (Juvederm VOLUMA) for temporarily restoring volume in the mid-face area. About 149 adults aged 19 to 65 who want to improve mid-face volume loss are participating. The goal is to see if JTM102 is safe and effective for this cosmetic concern.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MID FACE VOLUME DEFICIT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungang University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.